"pancreatic ductal adenocarcinoma" trang 2 - tải miễn phí từ tailieuXANH
PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
12    60    0
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
9    62    0
Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma
8    40    0
Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma

Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma
9    56    0
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review

Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review
17    51    1
Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
18    182    1
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma
9    247    1
Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: A real-world study of 2010 patients

Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: A real-world study of 2010 patients
11    89    2
Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma

Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma
20    300    1
Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: A retrospective cohort study
14    34    1
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: A prospective observational study

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: A prospective observational study
11    178    1
The identification of liver metastasisand prognosis-associated genes in pancreatic ductal adenocarcinoma

The identification of liver metastasisand prognosis-associated genes in pancreatic ductal adenocarcinoma
14    21    1
Proposal for a definition of

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
13    67    0
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
9    63    0
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice
8    82    0
GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: Immunohistochemistry study showing the correlation between expression and survival

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: Immunohistochemistry study showing the correlation between expression and survival
9    52    0
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy

Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy
12    51    1
Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols

Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols
10    87    1
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study
9    90    0
Regulation of pancreatic stellate cell activation by Notch3

Regulation of pancreatic stellate cell activation by Notch3
12    79    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.